Functions of IL-15 in anti-viral immunity: Multiplicity and variety

Cytokine

Volumn 59, Issue 3, 2012, Pages 467-478

  Verbist, Katherine C ^a   Klonowski, Kimberly D ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

c; Anti viral immunity; CD8 T cells; IL 15; Immune intervention; NK; NK cells; Teff; Tmem

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD122 ANTIBODY; CD8 ANTIGEN; COAT PROTEIN; CYTOKINE; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 15 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR BETA; PLASMID DNA; RECOMBINANT INTERLEUKIN 15; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOKINE RELEASE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG MEGADOSE; HEPATITIS B; HERPES SIMPLEX; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; LOW DRUG DOSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MONKEYPOX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROVIRUS INFECTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC DISEASE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE SPECIFICITY; TREATMENT RESPONSE; VIRAL CLEARANCE; VIREMIA; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS LOAD;

ANIMALS; HUMANS; IMMUNITY; INTERLEUKIN-15; LYMPHOCYTES; VIRUS DISEASES; VIRUSES;

ERAGROSTIS TEF;

EID: 84864971523     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.05.020     Document Type: Review

References (155)

1. Bamford R.N., Grant A.J., Burton J.D., Peters C., Kurys G., Goldman C.K., et al. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994, 91:4940-4944.
2. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
3. Bamford R.N., Battiata A.P., Burton J.D., Sharma H., Waldmann T.A. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc Natl Acad Sci USA 1996, 93:2897-2902.
4. Budagian V., Bulanova E., Paus R., Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 2006, 17:259-280.
5. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990, 87:6934-6938.
6. Anderson D.M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 1995, 270:29862-29869.
7. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994, 13:2822-2830.
8. Giri J.G., Anderson D.M., Kumaki S., Park L.S., Grabstein K.H., Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 1995, 57:763-766.
9. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995, 14:3654-3663.
10. Dubois S., Mariner J., Waldmann T.A., Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002, 17:537-547.
11. Wuest S.C., Edwan J.H., Martin J.F., Han S., Perry J.S., Cartagena C.M., et al. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat Med 2011, 17:604-609.
12. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001, 14:105-110.
13. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994, 180:1395-1403.
14. Kennedy M.K., Park L.S. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 1996, 16:134-143.
15. Armitage R.J., Macduff B.M., Eisenman J., Paxton R., Grabstein K.H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995, 154:483-490.
16. Lenardo M.J. Fas and the art of lymphocyte maintenance. J Exp Med 1996, 183:721-724.
17. Marks-Konczalik J., Dubois S., Losi J.M., Sabzevari H., Yamada N., Feigenbaum L., et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 2000, 97:11445-11450.
18. Ma A., Koka R., Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 2006, 24:657-679.
19. Angiolillo A.L., Kanegane H., Sgadari C., Reaman G.H., Tosato G. Interleukin-15 promotes angiogenesis in vivo. Biochem Biophys Res Commun 1997, 233:231-237.
20. Quinn L.S., Anderson B.G., Drivdahl R.H., Alvarez B., Argiles J.M. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 2002, 280:55-63.
21. Verma S., Hiby S.E., Loke Y.W., King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000, 62:959-968.
22. Stone K.P., Kastin A.J., Pan W. NFkB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol 2011, 28:115-124.
23. Alvarez B., Carbo N., Lopez-Soriano J., Drivdahl R.H., Busquets S., Lopez-Soriano F.J., et al. Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta 2002, 1570:33-37.
24. Bamford R.N., DeFilippis A.P., Azimi N., Kurys G., Waldmann T.A. The 5' untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J Immunol 1998, 160:4418-4426.
25. Bamford R.N., Battiata A.P., Waldmann T.A. IL-15: the role of translational regulation in their expression. J Leukoc Biol 1996, 59:476-480.
26. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996, 4:329-336.
27. Di Sabatino A., Calarota S.A., Vidali F., Macdonald T.T., Corazza G.R. Role of IL-15 in immune-mediated and infectious diseases. Cytokine Growth Factor Rev 2011, 22:19-33.
28. Sun J.C., Lanier L.L. NK cell development, homeostasis and function: parallels with CD8 T cells. Nat Rev Immunol 2011, 11:645-657.
29. Vosshenrich C.A., Ranson T., Samson S.I., Corcuff E., Colucci F., Rosmaraki E.E., et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005, 174:1213-1221.
30. Lodolce J., Burkett P., Koka R., Boone D., Chien M., Chan F., et al. Interleukin-15 and the regulation of lymphoid homeostasis. Mol Immunol 2002, 39:537-544.
31. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998, 9:669-676.
32. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000, 191:771-780.
33. DiSanto J.P. Cytokines: shared receptors, distinct functions. Curr Biol 1997, 7:R424-426.
34. Puzanov I.J., Bennett M., Kumar V. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol 1996, 157:4282-4285.
35. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998, 391:700-703.
36. Ohteki T., Ho S., Suzuki H., Mak T.W., Ohashi P.S. Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J Immunol 1997, 159:5931-5935.
37. Gascoyne D.M., Long E., Veiga-Fernandes H., de Boer J., Williams O., Seddon B., et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 2009, 10:1118-1124.
38. Kamizono S., Duncan G.S., Seidel M.G., Morimoto A., Hamada K., Grosveld G., et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J Exp Med 2009, 206:2977-2986.
39. Moretta L., Bottino C., Pende D., Vitale M., Mingari M.C., Moretta A. Different checkpoints in human NK-cell activation. Trends Immunol 2004, 25:670-676.
40. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
41. Kawamura T., Koka R., Ma A., Kumar V. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction. J Immunol 2003, 171:5085-5090.
42. -/- mice. J Immunol 2011, 187:5162-5169.
43. Lee G.A., Liou Y.H., Wang S.W., Ko K.L., Jiang S.T., Liao N.S. Different NK cell developmental events require different levels of IL-15 trans-presentation. J Immunol 2011, 187:1212-1221.
44. Soderquest K., Powell N., Luci C., van Rooijen N., Hidalgo A., Geissmann F., et al. Monocytes control natural killer cell differentiation to effector phenotypes. Blood 2011, 117:4511-4518.
45. Pek E.A., Chan T., Reid S., Ashkar A.A. Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology 2011, 216:218-224.
46. Cooper M.A., Bush J.E., Fehniger T.A., VanDeusen J.B., Waite R.E., Liu Y., et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002, 100:3633-3638.
47. Koka R., Burkett P.R., Chien M., Chai S., Chan F., Lodolce J.P., et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 2003, 197:977-984.
48. Huntington N.D., Puthalakath H., Gunn P., Naik E., Michalak E.M., Smyth M.J., et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol 2007, 8:856-863.
49. Prlic M., Blazar B.R., Farrar M.A., Jameson S.C. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 2003, 197:967-976.
50. Castillo E.F., Stonier S.W., Frasca L., Schluns K.S. Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation. J Immunol 2009, 183:4948-4956.
51. Stoklasek T.A., Schluns K.S., Lefrancois L. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol 2006, 177:6072-6080.
52. Pillet A.H., Theze J., Rose T. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes. Hum Immunol 2011, 72:1013-1017.
53. Minagawa M., Watanabe H., Miyaji C., Tomiyama K., Shimura H., Ito A., et al. Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor beta-chain-deficient mice. J Immunol 2002, 169:4153-4160.
54. Park J.Y., Lee S.H., Yoon S.R., Park Y.J., Jung H., Kim T.D., et al. IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells. Mol Cells 2011, 32:265-272.
55. Moustaki A., Argyropoulos K.V., Baxevanis C.N., Papamichail M., Perez S.A. Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function. Cancer Immunol Immunother 2011, 60:1683-1695.
56. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002, 195:327-333.
57. Koka R., Burkett P., Chien M., Chai S., Boone D.L., Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 2004, 173:3594-3598.
58. Elpek K.G., Rubinstein M.P., Bellemare-Pelletier A., Goldrath A.W., Turley S.J. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes. Proc Natl Acad Sci USA 2010, 107:21647-21652.
59. Dokun A.O., Chu D.T., Yang L., Bendelac A.S., Yokoyama W.M. Analysis of in situ NK cell responses during viral infection. J Immunol 2001, 167:5286-5293.
60. Allavena P., Giardina G., Bianchi G., Mantovani A. IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J Leukoc Biol 1997, 61:729-735.
61. Barlic J., Sechler J.M., Murphy P.M. IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 2003, 102:3494-3503.
62. Barlic J., McDermott D.H., Merrell M.N., Gonzales J., Via L.E., Murphy P.M. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms. J Biol Chem 2004, 279:48520-48534.
63. Sechler J.M., Barlic J., Grivel J.C., Murphy P.M. IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells. Cell Immunol 2004, 230:99-108.
64. Carroll H.P., Paunovic V., Gadina M. Signalling, inflammation and arthritis: crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology (Oxford) 2008, 47:1269-1277.
65. Dubsky P., Saito H., Leogier M., Dantin C., Connolly J.E., Banchereau J., et al. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Eur J Immunol 2007, 37:1678-1690.
66. Pulendran B., Dillon S., Joseph C., Curiel T., Banchereau J., Mohamadzadeh M. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo. Eur J Immunol 2004, 34:66-73.
67. Kuwajima S., Sato T., Ishida K., Tada H., Tezuka H., Ohteki T. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol 2006, 7:740-746.
68. Ruckert R., Brandt K., Bulanova E., Mirghomizadeh F., Paus R., Bulfone-Paus S. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol 2003, 33:3493-3503.
69. Feau S., Facchinetti V., Granucci F., Citterio S., Jarrossay D., Seresini S., et al. Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 2005, 105:697-702.
70. Becker T.C., Wherry E.J., Boone D., Murali-Krishna K., Antia R., Ma A., et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002, 195:1541-1548.
71. Wherry E.J., Becker T.C., Boone D., Kaja M.K., Ma A., Ahmed R. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha. Adv Exp Med Biol 2002, 512:165-175.
72. Harris K.M. Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15. J Leukoc Biol 2011, 90:727-734.
73. Hardy M.Y., Kassianos A.J., Vulink A., Wilkinson R., Jongbloed S.L., Hart D.N., et al. NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells. Immunol Cell Biol 2009, 87:606-614.
74. Mattei F., Schiavoni G., Belardelli F., Tough D.F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 2001, 167:1179-1187.
75. Kuniyoshi J.S., Kuniyoshi C.J., Lim A.M., Wang F.Y., Bade E.R., Lau R., et al. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell Immunol 1999, 193:48-58.
76. Zhang X., Sun S., Hwang I., Tough D.F., Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998, 8:591-599.
77. Ishii H., Takahara M., Nagato T., Kis L.L., Nagy N., Kishibe K., et al. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. Int J Cancer 2012, 130:48-58.
78. Boudreau J.E., Stephenson K.B., Wang F., Ashkar A.A., Mossman K.L., Lenz L.L., et al. IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells. Cancer Res 2011, 71:2497-2506.
79. Vujanovic L., Szymkowski D.E., Alber S., Watkins S.C., Vujanovic N.L., Butterfield L.H. Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15. Blood 2010, 116:575-583.
80. Schluns K.S., Williams K., Ma A., Zheng X.X., Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002, 168:4827-4831.
81. McGill J., Van Rooijen N., Legge K.L. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med 2010, 207:521-534.
82. Oh S., Perera L.P., Terabe M., Ni L., Waldmann T.A., Berzofsky J.A. IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci USA 2008, 105:5201-5206.
83. Bodnar A., Nizsaloczki E., Mocsar G., Szaloki N., Waldmann T.A., Damjanovich S., et al. A biophysical approach to IL-2 and IL-15 receptor function: localization, conformation and interactions. Immunol Lett 2008, 116:117-125.
84. Johnston J.A., Bacon C.M., Finbloom D.S., Rees R.C., Kaplan D., Shibuya K., et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 1995, 92:8705-8709.
85. Lin J.X., Migone T.S., Tsang M., Friedmann M., Weatherbee J.A., Zhou L., et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995, 2:331-339.
86. Miyazaki T., Liu Z.J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 1995, 81:223-231.
87. Leclercq G., Debacker V., de Smedt M., Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med 1996, 184:325-336.
88. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
89. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
90. Porter B.O., Malek T.R. IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development. J Immunol 1999, 163:5906-5912.
91. Yajima T., Nishimura H., Ishimitsu R., Watase T., Busch D.H., Pamer E.G., et al. Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure. J Immunol 2002, 168:1198-1203.
92. Fehniger T.A., Suzuki K., Ponnappan A., VanDeusen J.B., Cooper M.A., Florea S.M., et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med 2001, 193:219-231.
93. Stoklasek T.A., Colpitts S.L., Smilowitz H.M., Lefrancois L. MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Ralpha complex. J Immunol 2010, 185:6857-6865.
94. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001, 98:8732-8737.
95. Tan J.T., Ernst B., Kieper W.C., LeRoy E., Sprent J., Surh C.D. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002, 195:1523-1532.
96. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000, 1:426-432.
97. Sandau M.M., Winstead C.J., Jameson S.C. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J Immunol 2007, 179:120-125.
98. Goldrath A.W., Bogatzki L.Y., Bevan M.J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000, 192:557-564.
99. Bulfone-Paus S., Durkop H., Paus R., Krause H., Pohl T., Onu A. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 1997, 9:507-513.
100. Vella A.T., Dow S., Potter T.A., Kappler J., Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998, 95:3810-3815.
101. Rubinstein M.P., Kadima A.N., Salem M.L., Nguyen C.L., Gillanders W.E., Cole D.J. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells. J Immunol 2002, 169:4928-4935.
102. Castro I., Yu A., Dee M.J., Malek T.R. The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development. J Immunol 2011, 187:5170-5182.
103. Mitchell D.M., Ravkov E.V., Williams M.A., et al. Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells. J Immunol 2010.
104. Yajima T., Yoshihara K., Nakazato K., Kumabe S., Koyasu S., Sad S., et al. IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol 2006, 176:507-515.
105. Sanjabi S., Mosaheb M.M., Flavell R.A. Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells. Immunity 2009, 31:131-144.
106. Rubinstein M.P., Lind N.A., Purton J.F., Filippou P., Best J.A., McGhee P.A., et al. IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response. Blood 2008, 112:3704-3712.
107. Ota N., Takase M., Uchiyama H., Olsen S.K., Kanagawa O. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation. J Immunol 2010, 185:6041-6048.
108. Huntington N.D., Alves N.L., Legrand N., Lim A., Strick-Marchand H., Mention J.J., et al. IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc Natl Acad Sci USA 2011, 108:6217-6222.
109. Wilkinson P.C., Liew F.Y. Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 1995, 181:1255-1259.
110. McInnes I.B., al-Mughales J., Field M., Leung B.P., Huang F.P., Dixon R., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996, 2:175-182.
111. Verbist K.C., Cole C.J., Field M.B., Klonowski K.D. A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection. J Immunol 2011, 186:174-182.
112. Perera L.P., Goldman C.K., Waldmann T.A. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol 1999, 162:2606-2612.
113. Azimi N., Jacobson S., Leist T., Waldmann T.A. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol 1999, 163:4064-4072.
114. Azimi N., Nagai M., Jacobson S., Waldmann T.A. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci USA 2001, 98:14559-14564.
115. Enose-Akahata Y., Oh U., Grant C., Jacobson S. Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood 2008, 112:2400-2410.
116. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012, 481:394-398.
117. Obar J.J., Crist S.G., Leung E.K., Usherwood E.J. IL-15-independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection. J Immunol 2004, 173:2705-2714.
118. Verbist K.C., Field M.B., Klonowski K.D. Cutting edge: IL-15-independent maintenance of mucosally generated memory CD8 T cells. J Immunol 2011, 186:6667-6671.
119. Shen C.H., Ge Q., Talay O., Eisen H.N., Garcia-Sastre A., Chen J. Loss of IL-7R and IL-15R expression is associated with disappearance of memory T cells in respiratory tract following influenza infection. J Immunol 2008, 180:171-178.
120. Dunn C., Peppa D., Khanna P., Nebbia G., Jones M., Brendish N., et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009, 137:1289-1300.
121. Meier U.C., Owen R.E., Taylor E., Worth A., Naoumov N., Willberg C., et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005, 79:12365-12374.
122. Zdrenghea M.T., Telcian A.G., Laza-Stanca V., Bellettato C.M., Edwards M.R., Nikonova A., et al. RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells. Eur Resp J 2011, 39:712-720.
123. Ashkar A.A., Rosenthal K.L. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 2003, 77:10168-10171.
124. Gosselin J., TomoIu A., Gallo R.C., Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 1999, 94:4210-4219.
125. Gill N., Rosenthal K.L., Ashkar A.A. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol 2005, 79:4470-4478.
126. Thatte A., DeWitte-Orr S.J., Lichty B., Mossman K.L., Ashkar A.A. A critical role for IL-15 in TLR-mediated innate antiviral immunity against genital HSV-2 infection. Immunol Cell Biol 2011, 89:663-669.
127. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
128. Gill N., Ashkar A.A. Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2. J Virol 2009, 83:918-926.
129. Leone A., Picker L.J., Sodora D.L. IL-2, IL-7 and IL-15 as immuno-modulators during SIV/HIV vaccination and treatment. Curr HIV Res 2009, 7:83-90.
130. Calarota S.A., Dai A., Trocio J.N., Weiner D.B., Lori F., Lisziewicz J. IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine 2008, 26:5188-5195.
131. Mueller Y.M., Bojczuk P.M., Halstead E.S., Kim A.H., Witek J., Altman J.D., et al. IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 2003, 101:1024-1029.
132. Picker L.J., Reed-Inderbitzin E.F., Hagen S.I., Edgar J.B., Hansen S.G., Legasse A., et al. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest 2006, 116:1514-1524.
133. Valentin A., von Gegerfelt A., Rosati M., Miteloudis G., Alicea C., Bergamaschi C., et al. Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine 2010, 28:1962-1974.
134. Villinger F., Miller R., Mori K., Mayne A.E., Bostik P., Sundstrom J.B., et al. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 2004, 22:3510-3521.
135. Ward J., Barker E. Role of natural killer cells in HIV pathogenesis. Current HIV/AIDS Rep 2008, 5:44-50.
136. Ahmad A., Ahmad R., Iannello A., Toma E., Morisset R., Sindhu S.T. IL-15 and HIV infection: lessons for immunotherapy and vaccination. Curr HIV Res 2005, 3:261-270.
137. Mueller K., Schweier O., Pircher H. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy. Eur J Immunol 2008, 38:2874-2885.
138. Demberg T., Robert-Guroff M. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol 2009, 28:20-48.
139. Eberly M.D., Kader M., Hassan W., Rogers K.A., Zhou J., Mueller Y.M., et al. Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J Immunol 2009, 182:1439-1448.
140. Mueller Y.M., Petrovas C., Bojczuk P.M., Dimitriou I.D., Beer B., Silvera P., et al. Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. J Virol 2005, 79:4877-4885.
141. d'Ettorre G., Andreotti M., Ceccarelli G., Galluzzo C.M., Mallano A., Massetti A.P., et al. The role of IL-15 in challenging acquired immunodeficiency syndrome. Cytokine 2012, 57:54-60.
142. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol 1998, 28:1089-1103.
143. Boyer J.D., Robinson T.M., Kutzler M.A., Vansant G., Hokey D.A., Kumar S., et al. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci USA 2007, 104:18648-18653.
144. Chong S.Y., Egan M.A., Kutzler M.A., Megati S., Masood A., Roopchard V., et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 2007, 25:4967-4982.
145. Hryniewicz A., Price D.A., Moniuszko M., Boasso A., Edghill-Spano Y., West S.M., et al. Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol 2007, 178:3492-3504.
146. Poon L.L., Leung Y.H., Nicholls J.M., Perera P.Y., Lichy J.H., Yamamoto M., et al. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol 2009, 182:3063-3071.
147. Zielinski R.J., Smedley J.V., Perera P.Y., Silvera P.M., Waldmann T.A., Capala J., et al. Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys. Vaccine 2010, 28:7081-7091.
148. Kwissa M., Kroger A., Hauser H., Reimann J., Schirmbeck R. Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination. J Mol Med (Berl) 2003, 81:91-101.
149. Cui F.D., Asada H., Jin M.L., Kishida T., Shin-Ya M., Nakaya T., et al. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Gene Ther 2005, 12:160-168.
150. Yin J., Dai A., Laddy D.J., Yan J., Arango T., Khan A.S., et al. High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. Virology 2009, 393:49-55.
151. Mortier E., Woo T., Advincula R., Gozalo S., Ma A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med 2008, 205:1213-1225.
152. Meazza R., Basso S., Gaggero A., Detotero D., Trentin L., Pereno R., et al. Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gamma. Int J Cancer 1998, 78:189-195.
153. Stevens A.C., Matthews J., Andres P., Baffis V., Zheng X.X., Chae D.W., et al. Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain. Am J Physiol 1997, 272:G1201-1208.
154. Bulfone-Pau S.S., Bulanova E., Pohl T., Budagian V., Durkop H., Ruckert R., et al. Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J 1999, 13:1575-1585.
155. Budagian V., Bulanova E., Orinska Z., Pohl T., Borden E.C., Silverman R., et al. Reverse signaling through membrane-bound interleukin-15. J Biol Chem 2004, 279:42192-42201.